Blue Heron Gets New CEO; Genomic Health OKs ’07 Salaries for Brass; Proteopure Names Invitrogen Alumnus to Board; and Others | GenomeWeb
NEW YORK (GenomeWeb News) — Ambit Biosciences, a small-molecule kinase-development company, has appointed Kerry Kelly to the position of vice president and general counsel, the company said Tuesday. Kelly recently was associate general counsel for The Scripps Research Institute and before that she was head of corporate affairs for biotech company Sugen, which has since been acquired by Pfizer.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.